All In Biotech

Drug Trial Radar · NCT05827016

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,230 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,230

Actual

Start

Jun 22, 2023

Primary completion

Mar 15, 2029

Study completion Jan 1, 2036

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Apr 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).

Conditions

  • Multiple Myeloma

Interventions

  • IberdomideDrug

    Specified dose on specified days

  • LenalidomideDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS)Time frame: Up to 6 years

Locations

269 sites in 34 countries. Site status is shown where the registry gives one.

  • Local Institution - 0202

    Aurora, Colorado

  • Local Institution - 0007

    Jacksonville, Florida

  • Local Institution - 0308

    Tampa, Florida

  • Local Institution - 0192

    Tampa, Florida

  • Local Institution - 0003

    Weston, Florida

  • Local Institution - 0019

    Athens, Georgia

  • Local Institution - 0018

    Atlanta, Georgia

  • Local Institution - 0021

    Augusta, Georgia

  • Local Institution - 0237

    Chicago, Illinois

  • University of Kansas Cancer Center - The Richard and Annette Bloch Cancer Care Pavilion

    Westwood, Kansas

  • Local Institution - 0205

    Clinton, Maryland

  • Local Institution - 0279

    Worcester, Massachusetts

  • Local Institution - 0001

    Ann Arbor, Michigan

  • Local Institution - 0257

    Detroit, Michigan

  • Local Institution - 0296

    Grand Rapids, Michigan

  • Local Institution - 0303

    Rochester, Minnesota

  • Local Institution - 0207

    Hattiesburg, Mississippi

  • Local Institution - 0191

    Morristown, New Jersey

  • Local Institution - 0328

    Brooklyn, New York

  • Local Institution - 0288

    Mineola, New York

  • Local Institution - 0180

    New York, New York

  • Local Institution - 0020

    New York, New York

  • Local Institution - 0274

    Westbury, New York

  • Local Institution - 0331

    Charlotte, North Carolina

  • Local Institution - 0005

    Charlotte, North Carolina

  • Local Institution - 0281

    Durham, North Carolina

  • Local Institution - 0286

    Winston-Salem, North Carolina

  • Local Institution - 0322

    Winston-Salem, North Carolina

  • Local Institution - 0238

    Cincinnati, Ohio

  • Local Institution - 0299

    Cleveland, Ohio

  • Local Institution - 0002

    Cleveland, Ohio

  • Local Institution - 0017

    Kansas, Ohio

  • Local Institution - 0301

    Mayfield Heights, Ohio

  • Local Institution - 0013

    Toledo, Ohio

  • Local Institution - 0300

    Wooster, Ohio

  • Local Institution - 0203

    Eugene, Oregon

  • Local Institution - 0012

    Philadelphia, Pennsylvania

  • Local Institution - 0011

    Philadelphia, Pennsylvania

  • Local Institution - 0253

    Pittsburgh, Pennsylvania

  • Local Institution - 0294

    Germantown, Tennessee

Showing 40 of 269 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.